IOBT FY 2020 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$18M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$10M

Net Income

-$12M

EPS (Diluted)

$-1.05

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$64,000

Balance Sheet

Total Assets

$6M

Total Liabilities

$3M

Stockholders' Equity

$3M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$10M	-$10M	-2.3%
Net Income	-$12M	-$11M	-12.0%